Prilenia Therapeutics B V : Prilenia Announces Clinical Data in Support of its Plans to Initiate Global Phase 3 Study in ALS finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
PROOF-HD is the only late-stage study in Huntington's disease targeting clinical progression; topline results expected in early Q2 2023 Prilenia Therapeutics B.V., a clinical stage biotechnology
The primary and key secondary endpoints did not reach statistical significance Beneficial effects were observed across several secondary and exploratory endpoints Both pre-specified
Prilenia Expands Leadership Team, Appoints Anne Sullivan as Chief Business Officer streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.